SCHEMBL31544917

SCHEMBL31544917

CCC(=C(C)C)C1CC(O)Oc2cc(C3CCCCC3)cc(O)c21

nearest known ligand 0.38

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 10/20 0.38
▸ CNR1 P21554 9/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31545115 0.75 CNR2 (0.46) CNR2CNR1
SCHEMBL31545328 0.74 CNR1 (0.45) CNR2CNR1
SCHEMBL31545137 0.74 CNR1 (0.45) CNR2CNR1
SCHEMBL31545360 0.73 CNR1 (0.37) CNR2CNR1
SCHEMBL31546013 0.70 KDR (0.34) —
SCHEMBL31545146 0.64 CNR2 (0.49) CNR2CNR1
SCHEMBL31544899 0.64 CNR2 (0.44) CNR2CNR1
SCHEMBL24212552 0.58 ALOX5 (0.47) —
SCHEMBL778084 0.56 CYP11B2 (0.46) —
SCHEMBL9722928 0.56 EPHX2 (0.47) CNR2CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250090554-A1 A METHOD OF TREATING DEPRESSION BY IMMUNE MODULATION MYND LIFE SCIENCES INC (CA) 2025-03-20 — — US disclosed
Send feedback